beta

ALT

Altimmune Inc.

Alt

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

11-13-2018 08-14-2018 05-15-2018 03-28-2018 11-09-2017 after market close 08-09-2017
Actual EPS -1.73 -0.16 -0.23 -0.12 -0.34 -0.26
Consensus EPS -3.6 -0.15 -0.5 -0.5 -0.23
Estimated EPS -3.6 -0.15 -0.5 -0.5 -0.23
Number of Estimates 1 1 1 1 1
EPS Surprise $1.87 -$0.01 $0.27 $0.38 -$0.11

Stats

Summary

Altimmune Inc is a clinical stage immunotherapeutic biotechnology company. It has two vaccine delivery platforms, RespirVec and Densigen.

Market Cap: 28.8 Million

Primary Exchange: NASDAQ Global Market

Website: http://www.altimmune.com

Shares Outstanding: 15.7 Million

Float: 10.6 Million

Dividend: 0.0 (0.0%)

Beta: 2.444308

Sector: Healthcare

Industry: Biotechnology

Short Interest (Jan 12, 2018): 646 Thousand

Ethical Flags

Animal testing

Longest drawdown: 479 trading days

From: 2017-01-10 To: 2018-12-14

Lowest Point:

Healthcare and consumer stocks down in premarket trade

via: SeekingAlpha at 2018-12-13 09:12:40:000

Applied Genetic Technologies (NASDAQ: AGTC ) -38% after gene therapy fails to show effect in XLRS study. More news on: Applied Genetic Technologies Corporation, Tailored Brands, Inc, Marinus Pharmaceuticals, Stocks on the move, , Read more … read more...

Healthcare and consumer stocks down in premarket trade

via: SeekingAlpha at 2018-12-13 09:12:40:000

Applied Genetic Technologies (NASDAQ: AGTC ) -38% after gene therapy fails to show effect in XLRS study. More news on: Applied Genetic Technologies Corporation, Tailored Brands, Inc, Marinus Pharmaceuticals, Stocks on the move, , Read more … read more...

Healthcare and consumer stocks down in premarket trade

via: SeekingAlpha at 2018-12-13 09:12:40:000

Applied Genetic Technologies (NASDAQ: AGTC ) -38% after gene therapy fails to show effect in XLRS study. More news on: Applied Genetic Technologies Corporation, Tailored Brands, Inc, Marinus Pharmaceuticals, Stocks on the move, , Read more … read more...

Altimmune slips 5% premarket on disappointing NasoShield data

via: SeekingAlpha at 2018-12-13 08:39:06:000

Nano cap Altimmune (NASDAQ: ALT ) is down 5% premarket on light volume on the heels of it update for investors on its pipeline activities. More news on: Altimmune, Inc., Healthcare stocks news, Stocks on the move, Read more … read more...

Altimmune slips 5% premarket on disappointing NasoShield data

via: SeekingAlpha at 2018-12-13 08:39:06:000

Nano cap Altimmune (NASDAQ: ALT ) is down 5% premarket on light volume on the heels of it update for investors on its pipeline activities. More news on: Altimmune, Inc., Healthcare stocks news, Stocks on the move, Read more … read more...

Altimmune slips 5% premarket on disappointing NasoShield data

via: SeekingAlpha at 2018-12-13 08:39:06:000

Nano cap Altimmune (NASDAQ: ALT ) is down 5% premarket on light volume on the heels of it update for investors on its pipeline activities. More news on: Altimmune, Inc., Healthcare stocks news, Stocks on the move, Read more … read more...

Altimmune: Suppressed, Immature, Or Dormant?

via: SeekingAlpha at 2018-12-05 15:22:22:000

2018 has been a volatile year for Altimmune ( ALT ) from start to finish. The company experienced mixed results in clinical trials as well as changes management positions. Unfortunately, the share price has taken the brunt of the losses and has gained little from the wins. After a reverse spli… read more...

Altimmune: Suppressed, Immature, Or Dormant?

via: SeekingAlpha at 2018-12-05 15:22:22:000

2018 has been a volatile year for Altimmune ( ALT ) from start to finish. The company experienced mixed results in clinical trials as well as changes management positions. Unfortunately, the share price has taken the brunt of the losses and has gained little from the wins. After a reverse spli… read more...

Altimmune: Suppressed, Immature, Or Dormant?

via: SeekingAlpha at 2018-12-05 15:22:22:000

2018 has been a volatile year for Altimmune ( ALT ) from start to finish. The company experienced mixed results in clinical trials as well as changes management positions. Unfortunately, the share price has taken the brunt of the losses and has gained little from the wins. After a reverse spli… read more...

Altimmune up 7% premarket after Q3 update

via: SeekingAlpha at 2018-11-14 08:58:56:000

Altimmune (NASDAQ: ALT ) is up 7% premarket on light volume in response to its Q3 report released after the close yesterday. Highlights: More news on: Altimmune, Inc., Healthcare stocks news, Earnings news and commentary, Stocks on the move, , Read more … read more...

Altimmune up 7% premarket after Q3 update

via: SeekingAlpha at 2018-11-14 08:58:56:000

Altimmune (NASDAQ: ALT ) is up 7% premarket on light volume in response to its Q3 report released after the close yesterday. Highlights: More news on: Altimmune, Inc., Healthcare stocks news, Earnings news and commentary, Stocks on the move, , Read more … read more...

Altimmune up 7% premarket after Q3 update

via: SeekingAlpha at 2018-11-14 08:58:56:000

Altimmune (NASDAQ: ALT ) is up 7% premarket on light volume in response to its Q3 report released after the close yesterday. Highlights: More news on: Altimmune, Inc., Healthcare stocks news, Earnings news and commentary, Stocks on the move, , Read more … read more...

Altimmune reports Q3 results

via: SeekingAlpha at 2018-11-13 16:54:15:000

Altimmune (NASDAQ: ALT ): Q3 GAAP EPS of -$1.73. More news on: Altimmune, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Altimmune (ALT) Presents At DAWSON JAMES 4th Annual Small Cap Growth Conference - Slideshow

via: SeekingAlpha at 2018-10-31 18:03:28:000

The following slide deck was published by Altimmune, Inc. in conjunction with this Read more … read more...

Altimmune (ALT) Presents At DAWSON JAMES 4th Annual Small Cap Growth Conference - Slideshow

via: SeekingAlpha at 2018-10-31 18:03:28:000

The following slide deck was published by Altimmune, Inc. in conjunction with this Read more … read more...

Altimmune (ALT) Presents At DAWSON JAMES 4th Annual Small Cap Growth Conference - Slideshow

via: SeekingAlpha at 2018-10-31 18:03:28:000

The following slide deck was published by Altimmune, Inc. in conjunction with this Read more … read more...

Midday Gainers / Losers (10/16/2018)

via: SeekingAlpha at 2018-10-16 12:44:53:000

Gainers: FFHL +73% . BLNK +38% . GTXI +26% . ALRN +22% . IFMK +18% . ALT +18% . HQCL +17% . NDLS +15% . SEND +15% . HMNY +15% . More news on: Fuwei Films (Holdings) Co., Ltd., Blink Charging Co., GTx, Inc., Stocks on the move, , Top stock market news, … read more...

Midday Gainers / Losers (10/16/2018)

via: SeekingAlpha at 2018-10-16 12:44:53:000

Gainers: FFHL +73% . BLNK +38% . GTXI +26% . ALRN +22% . IFMK +18% . ALT +18% . HQCL +17% . NDLS +15% . SEND +15% . HMNY +15% . More news on: Fuwei Films (Holdings) Co., Ltd., Blink Charging Co., GTx, Inc., Stocks on the move, , Top stock market news, … read more...

Midday Gainers / Losers (10/16/2018)

via: SeekingAlpha at 2018-10-16 12:44:53:000

Gainers: FFHL +73% . BLNK +38% . GTXI +26% . ALRN +22% . IFMK +18% . ALT +18% . HQCL +17% . NDLS +15% . SEND +15% . HMNY +15% . More news on: Fuwei Films (Holdings) Co., Ltd., Blink Charging Co., GTx, Inc., Stocks on the move, , Top stock market news, … read more...

Weekly market movement wrap

via: SeekingAlpha at 2018-10-13 17:35:40:000

See a week over week comparison below for the following indices, equities, commodities, bonds and currencies. More news on: Youngevity International, Inc., CorMedix Inc., Pyxus International, Inc., Top stock market news, Quick stock ideas, News on the U.S. economy, Financial stocks news, H… read more...

Weekly market movement wrap

via: SeekingAlpha at 2018-10-13 17:35:40:000

See a week over week comparison below for the following indices, equities, commodities, bonds and currencies. More news on: Youngevity International, Inc., CorMedix Inc., Pyxus International, Inc., Top stock market news, Quick stock ideas, News on the U.S. economy, Financial stocks news, H… read more...

Weekly market movement wrap

via: SeekingAlpha at 2018-10-13 17:35:40:000

See a week over week comparison below for the following indices, equities, commodities, bonds and currencies. More news on: Youngevity International, Inc., CorMedix Inc., Pyxus International, Inc., Top stock market news, Quick stock ideas, News on the U.S. economy, Financial stocks news, H… read more...

Altimmune Declines Too Much

via: SeekingAlpha at 2018-10-09 15:41:37:000

Currently trading at 0.52x its book value per share after several equity transactions, Altimmune (ALT) seems a bit undervalued as compared to peers. The company sold large amount of warrants that investors should not appreciate. With that, other peers are trading at 1.95x-4.4x book value per s… read more...

Altimmune Declines Too Much

via: SeekingAlpha at 2018-10-09 15:41:37:000

Currently trading at 0.52x its book value per share after several equity transactions, Altimmune (ALT) seems a bit undervalued as compared to peers. The company sold large amount of warrants that investors should not appreciate. With that, other peers are trading at 1.95x-4.4x book value per s… read more...

Altimmune Declines Too Much

via: SeekingAlpha at 2018-10-09 15:41:37:000

Currently trading at 0.52x its book value per share after several equity transactions, Altimmune (ALT) seems a bit undervalued as compared to peers. The company sold large amount of warrants that investors should not appreciate. With that, other peers are trading at 1.95x-4.4x book value per s… read more...

Altimmune announces $25M registered direct offering; shares down 31% premarket

via: SeekingAlpha at 2018-10-08 09:28:04:000

Altimmune (NASDAQ: ALT ) has entered into a purchase agreement with several institutional investors for the purchase of common units and pre-funded units for a combined total of 4,629,630 units in a registered direct offering, for expected gross proceeds of ~$25M. More news on: Altimmune… read more...

Premarket Losers as of 9:05 am (10/8/2018)

via: SeekingAlpha at 2018-10-08 09:08:23:000

ALT -32% on announcing $25M registered direct offering. More news on: Altimmune, Inc., vTv Therapeutics, GTx, Inc., Stocks on the move, Top stock market news, , Read more … read more...

Midday Gainers / Losers (10/01/2018)

via: SeekingAlpha at 2018-10-01 12:40:08:000

Gainers: OGEN +51% . LEVB +37% . NBEV +39% . ARCW +30% . NTGN +27% . IGC +25% . IFMK +24% . ACST +21% . ATLC +21% . ALT +21% . More news on: Oragenics, Inc., Level Brands, Inc., New Age Beverages Corporation, Stocks on the move, , Read more … read more...

Midday Gainers / Losers (10/01/2018)

via: SeekingAlpha at 2018-10-01 12:40:08:000

Gainers: OGEN +51% . LEVB +37% . NBEV +39% . ARCW +30% . NTGN +27% . IGC +25% . IFMK +24% . ACST +21% . ATLC +21% . ALT +21% . More news on: Oragenics, Inc., Level Brands, Inc., New Age Beverages Corporation, Stocks on the move, , Read more … read more...

Midday Gainers / Losers (10/01/2018)

via: SeekingAlpha at 2018-10-01 12:40:08:000

Gainers: OGEN +51% . LEVB +37% . NBEV +39% . ARCW +30% . NTGN +27% . IGC +25% . IFMK +24% . ACST +21% . ATLC +21% . ALT +21% . More news on: Oragenics, Inc., Level Brands, Inc., New Age Beverages Corporation, Stocks on the move, , Read more … read more...

Midday Gainers / Losers (09/28/2018)

via: SeekingAlpha at 2018-09-28 12:40:43:000

Gainers: SYN +207% . IGC +36% . NBEV +31% . AYTU +23% . ZN +21% . CCXI +17% . IMMP +14% . SPNS +14% . PRSS +13% . AC +12% . More news on: Synthetic Biologics, Inc., India Globalization Capital, Inc, New Age Beverages Corporation, Stocks on the move, , Top s… read more...

Midday Gainers / Losers (09/28/2018)

via: SeekingAlpha at 2018-09-28 12:40:43:000

Gainers: SYN +207% . IGC +36% . NBEV +31% . AYTU +23% . ZN +21% . CCXI +17% . IMMP +14% . SPNS +14% . PRSS +13% . AC +12% . More news on: Synthetic Biologics, Inc., India Globalization Capital, Inc, New Age Beverages Corporation, Stocks on the move, , Top s… read more...

Midday Gainers / Losers (09/28/2018)

via: SeekingAlpha at 2018-09-28 12:40:43:000

Gainers: SYN +207% . IGC +36% . NBEV +31% . AYTU +23% . ZN +21% . CCXI +17% . IMMP +14% . SPNS +14% . PRSS +13% . AC +12% . More news on: Synthetic Biologics, Inc., India Globalization Capital, Inc, New Age Beverages Corporation, Stocks on the move, , Top s… read more...

Altimmune prices equity offering at $5/unit; shares down 49% premarket

via: SeekingAlpha at 2018-09-28 09:18:49:000

Thinly traded nano cap Altimmune (NASDAQ: ALT ) slumps 49% premarket on increased volume in response to its public offering of 2.4M unts at $5/unit. Each unit consists of one common share and one five-year warrant to purchase one common share at $6.00. More news on: Altimmune… read more...

Altimmune prices equity offering at $5/unit; shares down 49% premarket

via: SeekingAlpha at 2018-09-28 09:18:49:000

Thinly traded nano cap Altimmune (NASDAQ: ALT ) slumps 49% premarket on increased volume in response to its public offering of 2.4M unts at $5/unit. Each unit consists of one common share and one five-year warrant to purchase one common share at $6.00. More news on: Altimmune… read more...

Altimmune prices equity offering at $5/unit; shares down 49% premarket

via: SeekingAlpha at 2018-09-28 09:18:49:000

Thinly traded nano cap Altimmune (NASDAQ: ALT ) slumps 49% premarket on increased volume in response to its public offering of 2.4M unts at $5/unit. Each unit consists of one common share and one five-year warrant to purchase one common share at $6.00. More news on: Altimmune… read more...

Premarket Losers as of 9:05 am (9/28/2018)

via: SeekingAlpha at 2018-09-28 09:15:12:000

ALT -48% on pricing $12M Public Offering. More news on: Altimmune, Inc., Geron Corporation, Stocks on the move, Top stock market news, , Read more … read more...

Premarket Losers as of 9:05 am (9/28/2018)

via: SeekingAlpha at 2018-09-28 09:15:12:000

ALT -48% on pricing $12M Public Offering. More news on: Altimmune, Inc., Geron Corporation, Stocks on the move, Top stock market news, , Read more … read more...

Premarket Losers as of 9:05 am (9/28/2018)

via: SeekingAlpha at 2018-09-28 09:15:12:000

ALT -48% on pricing $12M Public Offering. More news on: Altimmune, Inc., Geron Corporation, Stocks on the move, Top stock market news, , Read more … read more...

Midday Gainers / Losers (09/27/2018)

via: SeekingAlpha at 2018-09-27 12:40:42:000

Gainers: ACHV +58% . RXII +36% . IGC +26% . GBR +25% . HAIR +20% . YGYI +18% . NTGN +17% . LQDA +16% . ARAY +17% . CCJ +16% . More news on: Achieve Life Sciences, Inc., RXI Pharmaceuticals Corporation, India Globalization Capital, Inc, Stocks on the mo… read more...

Altimmune readies equity offering; shares down 4% after hours

via: SeekingAlpha at 2018-09-26 21:37:49:000

Altimmune (NASDAQ: ALT ) has filed a preliminary prospectus for a public offering of 1,438,848 Common Units and the same number of Pre-Funded Units. More news on: Altimmune, Inc., Healthcare stocks news, Stocks on the move, Read more … read more...

Midday Gainers / Losers (09/26/2018)

via: SeekingAlpha at 2018-09-26 12:40:49:000

Gainers: ALDX +60% . VLRX +25% . IGC +23% . AGMH +21% . ELMD +21% . XOMA +13% . GWGH +13% . LQDA +13% . AVXL +14% . MMYT +12% . More news on: Aldeyra Therapeutics, Inc., Valeritas Holdings, Inc., India Globalization Capital, Inc, Stocks on the move, , Top s… read more...

Midday Gainers / Losers (09/24/2018)

via: SeekingAlpha at 2018-09-24 12:35:13:000

Gainers: AMRN +233% . SAEX +153% . GBR +41% . JONE +27% . IPCI +26% . XON +23% . CRC +17% . AGTC +16% . PEIX +15% . ACHV +15% . More news on: Amarin Corporation PLC, SAExploration Holdings, Inc., New Concept Energy, Inc., , Stocks on the move, Top stoc… read more...

Midday Gainers / Losers (09/24/2018)

via: SeekingAlpha at 2018-09-24 12:35:13:000

Gainers: AMRN +233% . SAEX +153% . GBR +41% . JONE +27% . IPCI +26% . XON +23% . CRC +17% . AGTC +16% . PEIX +15% . ACHV +15% . More news on: Amarin Corporation PLC, SAExploration Holdings, Inc., New Concept Energy, Inc., , Stocks on the move, Top stoc… read more...

Midday Gainers / Losers (09/20/2018)

via: SeekingAlpha at 2018-09-20 12:43:20:000

Gainers: ASCMA +95% . NBEV +64% . NVMM +47% . ALT +40% . CRBP +36% . AWSM +35% . YGYI +27% . LEVB +27% . OSN +21% . NIHD +20% . More news on: Ascent Capital Group, Inc., New Age Beverages Corporation, NOVUME SOLUTIONS INC, Stocks on the move, , Top sto… read more...

Midday Gainers / Losers (09/20/2018)

via: SeekingAlpha at 2018-09-20 12:43:20:000

Gainers: ASCMA +95% . NBEV +64% . NVMM +47% . ALT +40% . CRBP +36% . AWSM +35% . YGYI +27% . LEVB +27% . OSN +21% . NIHD +20% . More news on: Ascent Capital Group, Inc., New Age Beverages Corporation, NOVUME SOLUTIONS INC, Stocks on the move, , Top sto… read more...

Midday Gainers / Losers (09/20/2018)

via: SeekingAlpha at 2018-09-20 12:43:20:000

Gainers: ASCMA +95% . NBEV +64% . NVMM +47% . ALT +40% . CRBP +36% . AWSM +35% . YGYI +27% . LEVB +27% . OSN +21% . NIHD +20% . More news on: Ascent Capital Group, Inc., New Age Beverages Corporation, NOVUME SOLUTIONS INC, Stocks on the move, , Top sto… read more...

Vaxart up 12%

via: SeekingAlpha at 2018-09-20 11:16:19:000

Thinly traded nano cap Vaxart ( VXRT +12.4% ) is up 42% higher volume, albeit on modest turnover of 30K shares. The action appears to be connected to the rally in Altimmune ( ALT +72.1% ), up almost seven-fold in two days after announcing positive mid-stage data on flu vaccine candidate … read more...

Vaxart up 12%

via: SeekingAlpha at 2018-09-20 11:16:19:000

Thinly traded nano cap Vaxart ( VXRT +12.4% ) is up 42% higher volume, albeit on modest turnover of 30K shares. The action appears to be connected to the rally in Altimmune ( ALT +72.1% ), up almost seven-fold in two days after announcing positive mid-stage data on flu vaccine candidate … read more...

Vaxart up 12%

via: SeekingAlpha at 2018-09-20 11:16:19:000

Thinly traded nano cap Vaxart ( VXRT +12.4% ) is up 42% higher volume, albeit on modest turnover of 30K shares. The action appears to be connected to the rally in Altimmune ( ALT +72.1% ), up almost seven-fold in two days after announcing positive mid-stage data on flu vaccine candidate … read more...

Premarket Losers as of 9:05 am (9/20/2018)

via: SeekingAlpha at 2018-09-20 09:10:15:000

RRTS -15% on announcing plans for rights offering. More news on: Roadrunner Transportation Systems, Inc., Molecular Templates, Inc., Altimmune, Inc., Stocks on the move, Top stock market news, , Read more … read more...

Premarket Losers as of 9:05 am (9/20/2018)

via: SeekingAlpha at 2018-09-20 09:10:15:000

RRTS -15% on announcing plans for rights offering. More news on: Roadrunner Transportation Systems, Inc., Molecular Templates, Inc., Altimmune, Inc., Stocks on the move, Top stock market news, , Read more … read more...

Premarket Losers as of 9:05 am (9/20/2018)

via: SeekingAlpha at 2018-09-20 09:10:15:000

RRTS -15% on announcing plans for rights offering. More news on: Roadrunner Transportation Systems, Inc., Molecular Templates, Inc., Altimmune, Inc., Stocks on the move, Top stock market news, , Read more … read more...

Midday Gainers / Losers (09/19/2018)

via: SeekingAlpha at 2018-09-19 12:40:20:000

Gainers: ALT +71% . MTEM +67% . DCTH +61% . MOC +47% . TLRY +46% . NBEV +34% . IGC +21% . SAEX +21% . CRON +18% . NTEC +17% . More news on: Altimmune, Inc., Molecular Templates, Inc., Delcath Systems, Inc., Stocks on the move, , Top stock market news, … read more...

Altimmune jumps 99%

via: SeekingAlpha at 2018-09-19 11:13:28:000

Thinly traded nano cap Altimmune ( ALT +99.1% ) is up on an 11x surge in volume, albeit on turnover of only 387K shares. More news on: Altimmune, Inc., Healthcare stocks news, Stocks on the move, Read more … read more...

Altimmune -9.1% on offering of 58M units

via: SeekingAlpha at 2018-08-17 17:26:54:000

Altimmune (NASDAQ: ALT ) is off 9.1% after hours following a registration to offer nearly 58M units . More news on: Altimmune, Inc., Stocks on the move, Healthcare stocks news, Read more … read more...

Altimmune -9.1% on offering of 58M units

via: SeekingAlpha at 2018-08-17 17:26:54:000

Altimmune (NASDAQ: ALT ) is off 9.1% after hours following a registration to offer nearly 58M units . More news on: Altimmune, Inc., Stocks on the move, Healthcare stocks news, Read more … read more...

Altimmune -9.1% on offering of 58M units

via: SeekingAlpha at 2018-08-17 17:26:54:000

Altimmune (NASDAQ: ALT ) is off 9.1% after hours following a registration to offer nearly 58M units . More news on: Altimmune, Inc., Stocks on the move, Healthcare stocks news, Read more … read more...

Altimmune -9.1% on offering of 58M units

via: SeekingAlpha at 2018-08-17 17:26:54:000

Altimmune (NASDAQ: ALT ) is off 9.1% after hours following a registration to offer nearly 58M units . More news on: Altimmune, Inc., Stocks on the move, Healthcare stocks news, Read more … read more...

Altimmune -9.1% on offering of 58M units

via: SeekingAlpha at 2018-08-17 17:26:54:000

Altimmune (NASDAQ: ALT ) is off 9.1% after hours following a registration to offer nearly 58M units . More news on: Altimmune, Inc., Stocks on the move, Healthcare stocks news, Read more … read more...

Altimmune, Inc (ALT) CEO Bill Enright on Q2 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-08-15 10:05:05:000

Altimmune, Inc. (ALT) Q2 2018 Results Earnings Conference Call August 15, 2018, 08:30 AM ET Executives Bill Enright - CEO Will Brown - Acting CFO Analysts Presentation Operator Good morning everyone and welcome to the Altimmune Second Quarter 2018 Earnings Conference … read more...

Altimmune, Inc (ALT) CEO Bill Enright on Q2 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-08-15 10:05:05:000

Altimmune, Inc. (ALT) Q2 2018 Results Earnings Conference Call August 15, 2018, 08:30 AM ET Executives Bill Enright - CEO Will Brown - Acting CFO Analysts Presentation Operator Good morning everyone and welcome to the Altimmune Second Quarter 2018 Earnings Conference … read more...

Altimmune misses by $0.19, misses on revenue

via: SeekingAlpha at 2018-08-14 16:27:24:000

Altimmune (NASDAQ: ALT ): Q2 EPS of -$0.34 misses by $0.19 . Revenue of $2.41M (-20.7% Y/Y) misses by $0.6M . Shares +2.5% . Press Release More news on: Altimmune, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , read more...

Altimmune -16% on securities offering

via: SeekingAlpha at 2018-07-30 17:58:39:000

Nanocap Altimmune (NASDAQ: ALT ) has dropped 16.2% after hours after filing to offer up to $24M in units , via Roth Capital Partners. More news on: Altimmune, Inc., Healthcare stocks news, Stocks on the move, Read more … read more...

Altimmune -16% on securities offering

via: SeekingAlpha at 2018-07-30 17:58:39:000

Nanocap Altimmune (NASDAQ: ALT ) has dropped 16.2% after hours after filing to offer up to $24M in units , via Roth Capital Partners. More news on: Altimmune, Inc., Healthcare stocks news, Stocks on the move, Read more … read more...

Altimmune -16% on securities offering

via: SeekingAlpha at 2018-07-30 17:58:39:000

Nanocap Altimmune (NASDAQ: ALT ) has dropped 16.2% after hours after filing to offer up to $24M in units , via Roth Capital Partners. More news on: Altimmune, Inc., Healthcare stocks news, Stocks on the move, Read more … read more...

A High-Throughput Screen For Cancer Stocks That Have Few (Or No) Fundamentals

via: SeekingAlpha at 2018-06-16 09:00:00:000

Author's note: This article was presented early to subscribers of the Total Pharma Tracker , and they also got further insight into how best to use these tools in making investment decisions. Biotech holds a special place in my heart, both for the way it captures the imagination and for… read more...

A High-Throughput Screen For Cancer Stocks That Have Few (Or No) Fundamentals

via: SeekingAlpha at 2018-06-16 09:00:00:000

Author's note: This article was presented early to subscribers of the Total Pharma Tracker , and they also got further insight into how best to use these tools in making investment decisions. Biotech holds a special place in my heart, both for the way it captures the imagination and for… read more...

A High-Throughput Screen For Cancer Stocks That Have Few (Or No) Fundamentals

via: SeekingAlpha at 2018-06-16 09:00:00:000

Author's note: This article was presented early to subscribers of the Total Pharma Tracker , and they also got further insight into how best to use these tools in making investment decisions. Biotech holds a special place in my heart, both for the way it captures the imagination and for… read more...

A High-Throughput Screen For Cancer Stocks That Have Few (Or No) Fundamentals

via: SeekingAlpha at 2018-06-16 09:00:00:000

Author's note: This article was presented early to subscribers of the Total Pharma Tracker , and they also got further insight into how best to use these tools in making investment decisions. Biotech holds a special place in my heart, both for the way it captures the imagination and for… read more...

Altimmune's (ALT) CEO Bill Enright on Q1 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-05-16 11:47:07:000

Altimmune, Inc. (ALT) Q1 2018 Results Earnings Conference Call May 16, 2018 05:00 PM ET Executives Bill Enright - CEO Will Brown - Acting CFO Analysts David Sherman - LifeSci Capital Presentation Operator Good day and welcome to the Altimmune First Quarter 2018 Earn… read more...

Altimmune's (ALT) CEO Bill Enright on Q1 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-05-16 11:47:07:000

Altimmune, Inc. (ALT) Q1 2018 Results Earnings Conference Call May 16, 2018 05:00 PM ET Executives Bill Enright - CEO Will Brown - Acting CFO Analysts David Sherman - LifeSci Capital Presentation Operator Good day and welcome to the Altimmune First Quarter 2018 Earn… read more...

Altimmune's (ALT) CEO Bill Enright on Q1 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-05-16 11:47:07:000

Altimmune, Inc. (ALT) Q1 2018 Results Earnings Conference Call May 16, 2018 05:00 PM ET Executives Bill Enright - CEO Will Brown - Acting CFO Analysts David Sherman - LifeSci Capital Presentation Operator Good day and welcome to the Altimmune First Quarter 2018 Earn… read more...

Altimmune's (ALT) CEO Bill Enright on Q1 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-05-16 11:47:07:000

Altimmune, Inc. (ALT) Q1 2018 Results Earnings Conference Call May 16, 2018 05:00 PM ET Executives Bill Enright - CEO Will Brown - Acting CFO Analysts David Sherman - LifeSci Capital Presentation Operator Good day and welcome to the Altimmune First Quarter 2018 Earn… read more...

Altimmune's (ALT) CEO Bill Enright on Q1 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-05-16 11:47:07:000

Altimmune, Inc. (ALT) Q1 2018 Results Earnings Conference Call May 16, 2018 05:00 PM ET Executives Bill Enright - CEO Will Brown - Acting CFO Analysts David Sherman - LifeSci Capital Presentation Operator Good day and welcome to the Altimmune First Quarter 2018 Earn… read more...

Altimmune's (ALT) CEO Bill Enright on Q1 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-05-16 11:47:07:000

Altimmune, Inc. (ALT) Q1 2018 Results Earnings Conference Call May 16, 2018 05:00 PM ET Executives Bill Enright - CEO Will Brown - Acting CFO Analysts David Sherman - LifeSci Capital Presentation Operator Good day and welcome to the Altimmune First Quarter 2018 Earn… read more...

Altimmune beats by $0.27, beats on revenue

via: SeekingAlpha at 2018-05-15 16:52:55:000

Altimmune (NASDAQ: ALT ): Q1 EPS of -$0.23 beats by $0.27 . Revenue of $2.7M (+800.0% Y/Y) beats by $1.5M . Shares +14.3% . Press Release More news on: Altimmune, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , read more...

Altimmune beats by $0.27, beats on revenue

via: SeekingAlpha at 2018-05-15 16:52:55:000

Altimmune (NASDAQ: ALT ): Q1 EPS of -$0.23 beats by $0.27 . Revenue of $2.7M (+800.0% Y/Y) beats by $1.5M . Shares +14.3% . Press Release More news on: Altimmune, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , read more...

Altimmune beats by $0.27, beats on revenue

via: SeekingAlpha at 2018-05-15 16:52:55:000

Altimmune (NASDAQ: ALT ): Q1 EPS of -$0.23 beats by $0.27 . Revenue of $2.7M (+800.0% Y/Y) beats by $1.5M . Shares +14.3% . Press Release More news on: Altimmune, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , read more...

Altimmune beats by $0.27, beats on revenue

via: SeekingAlpha at 2018-05-15 16:52:55:000

Altimmune (NASDAQ: ALT ): Q1 EPS of -$0.23 beats by $0.27 . Revenue of $2.7M (+800.0% Y/Y) beats by $1.5M . Shares +14.3% . Press Release More news on: Altimmune, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , read more...

Altimmune beats by $0.27, beats on revenue

via: SeekingAlpha at 2018-05-15 16:52:55:000

Altimmune (NASDAQ: ALT ): Q1 EPS of -$0.23 beats by $0.27 . Revenue of $2.7M (+800.0% Y/Y) beats by $1.5M . Shares +14.3% . Press Release More news on: Altimmune, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , read more...

Altimmune beats by $0.27, beats on revenue

via: SeekingAlpha at 2018-05-15 16:52:55:000

Altimmune (NASDAQ: ALT ): Q1 EPS of -$0.23 beats by $0.27 . Revenue of $2.7M (+800.0% Y/Y) beats by $1.5M . Shares +14.3% . Press Release More news on: Altimmune, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , read more...

Altimmune beats by $0.27, beats on revenue

via: SeekingAlpha at 2018-05-15 16:26:51:000

Altimmune (NASDAQ: ALT ): Q1 EPS of -$0.23 beats by $0.27 . Revenue of $2.69M (+796.7% Y/Y) beats by $1.49M . Shares +10% . Press Release More news on: Altimmune, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , read more...

Altimmune beats by $0.27, beats on revenue

via: SeekingAlpha at 2018-05-15 16:26:51:000

Altimmune (NASDAQ: ALT ): Q1 EPS of -$0.23 beats by $0.27 . Revenue of $2.69M (+796.7% Y/Y) beats by $1.49M . Shares +10% . Press Release More news on: Altimmune, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , read more...

Altimmune beats by $0.27, beats on revenue

via: SeekingAlpha at 2018-05-15 16:26:51:000

Altimmune (NASDAQ: ALT ): Q1 EPS of -$0.23 beats by $0.27 . Revenue of $2.69M (+796.7% Y/Y) beats by $1.49M . Shares +10% . Press Release More news on: Altimmune, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , read more...

Altimmune beats by $0.27, beats on revenue

via: SeekingAlpha at 2018-05-15 16:26:51:000

Altimmune (NASDAQ: ALT ): Q1 EPS of -$0.23 beats by $0.27 . Revenue of $2.69M (+796.7% Y/Y) beats by $1.49M . Shares +10% . Press Release More news on: Altimmune, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , read more...

Altimmune beats by $0.27, beats on revenue

via: SeekingAlpha at 2018-05-15 16:26:51:000

Altimmune (NASDAQ: ALT ): Q1 EPS of -$0.23 beats by $0.27 . Revenue of $2.69M (+796.7% Y/Y) beats by $1.49M . Shares +10% . Press Release More news on: Altimmune, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , read more...

Altimmune beats by $0.27, beats on revenue

via: SeekingAlpha at 2018-05-15 16:26:51:000

Altimmune (NASDAQ: ALT ): Q1 EPS of -$0.23 beats by $0.27 . Revenue of $2.69M (+796.7% Y/Y) beats by $1.49M . Shares +10% . Press Release More news on: Altimmune, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , read more...

FDA accepts Sanofi Pasteur's marketing application for expanded use of flu vaccine

via: SeekingAlpha at 2018-04-25 09:45:07:000

The FDA accepts for review Sanofi Pasteur's ( SNY +0.6% ) supplemental marketing application seeking approval to use the 0.5 mL dose of Fluzone Quadrivalent (influenza vaccine) in children ages six months to 35 months. It is is currently approved for use in kids at least 36 months of age… read more...

FDA accepts Sanofi Pasteur's marketing application for expanded use of flu vaccine

via: SeekingAlpha at 2018-04-25 09:45:07:000

The FDA accepts for review Sanofi Pasteur's ( SNY +0.6% ) supplemental marketing application seeking approval to use the 0.5 mL dose of Fluzone Quadrivalent (influenza vaccine) in children ages six months to 35 months. It is is currently approved for use in kids at least 36 months of age… read more...

Altimmune (ALT) Presents At H. C. Wainwright Global Life Sciences Conference - Slideshow

via: SeekingAlpha at 2018-04-11 14:35:35:000

The following slide deck was published by Altimmune, Inc. in conjunction with this Read more … read more...

Altimmune (ALT) Presents At H. C. Wainwright Global Life Sciences Conference - Slideshow

via: SeekingAlpha at 2018-04-11 14:35:35:000

The following slide deck was published by Altimmune, Inc. in conjunction with this Read more … read more...

Altimmune's (ALT) CEO Bill Enright on Q4 2017 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-03-29 10:55:07:000

Altimmune, Inc. (ALT) Q4 2017 Earnings Conference Call March 29, 2018 08:00 ET Executives Paul Arndt - Investor Relations Bill Enright - Chief Executive Officer Elizabeth Czerepak - Chief Financial Officer and Executive Vice President, Corporate Development Sybil Tasker - Chief… read more...

Altimmune's (ALT) CEO Bill Enright on Q4 2017 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-03-29 10:55:07:000

Altimmune, Inc. (ALT) Q4 2017 Earnings Conference Call March 29, 2018 08:00 ET Executives Paul Arndt - Investor Relations Bill Enright - Chief Executive Officer Elizabeth Czerepak - Chief Financial Officer and Executive Vice President, Corporate Development Sybil Tasker - Chief… read more...

Altimmune reports FY results

via: SeekingAlpha at 2018-03-28 16:49:04:000

Altimmune (NASDAQ: ALT ): FY EPS of -$1.21 Revenue of $10.7M (+234.4% Y/Y) Press Release More news on: Altimmune, Inc., Earnings news and commentary, Healthcare stocks news, , read more...

Altimmune reports FY results

via: SeekingAlpha at 2018-03-28 16:49:04:000

Altimmune (NASDAQ: ALT ): FY EPS of -$1.21 Revenue of $10.7M (+234.4% Y/Y) Press Release More news on: Altimmune, Inc., Earnings news and commentary, Healthcare stocks news, , read more...

Midday Gainers / Losers (03/27/2018)

via: SeekingAlpha at 2018-03-27 12:59:05:000

Gainers: ASTC +32% . SHOS +31% . NSPR +28% . INNT +15% . TOPS +13% . MBII +13% . PETX +12% . HMNY +12% . ATNX +11% . MYOV +10% . More news on: Astrotech Corporation, Sears Hometown and Outlet Stores, Inc., InspireMD, Inc., , Read more … read more...

Midday Gainers / Losers (03/27/2018)

via: SeekingAlpha at 2018-03-27 12:59:05:000

Gainers: ASTC +32% . SHOS +31% . NSPR +28% . INNT +15% . TOPS +13% . MBII +13% . PETX +12% . HMNY +12% . ATNX +11% . MYOV +10% . More news on: Astrotech Corporation, Sears Hometown and Outlet Stores, Inc., InspireMD, Inc., , Read more … read more...

Premarket Gainers as of 9:05 am (03/13/2018)

via: SeekingAlpha at 2018-03-13 09:22:43:000

SPEX +52% to enter into cyber security market via DatChat acquisition. More news on: Spherix Incorporated, Proteostasis Therapeutics, Future Fintech Group Inc, Stocks on the move, , Read more … read more...

Premarket Gainers as of 9:05 am (03/13/2018)

via: SeekingAlpha at 2018-03-13 09:22:43:000

SPEX +52% to enter into cyber security market via DatChat acquisition. More news on: Spherix Incorporated, Proteostasis Therapeutics, Future Fintech Group Inc, Stocks on the move, , Read more … read more...

Altimmune +16% after data from anthrax vaccine program

via: SeekingAlpha at 2018-03-12 18:35:56:000

Altimmune (NASDAQ: ALT ) +16.6% after-hours following release of pre-clinical data from its SparVax-L anthrax vaccine program. More news on: Altimmune, Inc., Healthcare stocks news, Stocks on the move, Read more … read more...

Altimmune +16% after data from anthrax vaccine program

via: SeekingAlpha at 2018-03-12 18:35:56:000

Altimmune (NASDAQ: ALT ) +16.6% after-hours following release of pre-clinical data from its SparVax-L anthrax vaccine program. More news on: Altimmune, Inc., Healthcare stocks news, Stocks on the move, Read more … read more...

Altimmune (ALT) Presents At Noble Financial Capital Markets 14th Annual Investor Conference - Slideshow

via: SeekingAlpha at 2018-01-31 13:21:16:000

The following slide deck was published by Altimmune, Inc. in conjunction with this Read more … read more...

Altimmune (ALT) Presents At Noble Financial Capital Markets 14th Annual Investor Conference - Slideshow

via: SeekingAlpha at 2018-01-31 13:21:16:000

The following slide deck was published by Altimmune, Inc. in conjunction with this Read more … read more...

Altimmune (ALT) Presents At Noble Financial Capital Markets 14th Annual Investor Conference - Slideshow

via: SeekingAlpha at 2018-01-31 13:21:16:000

The following slide deck was published by Altimmune, Inc. in conjunction with this Read more … read more...

Your Daily Pharma Scoop: ChemoCentryx Surges, Akebia Gets Positive News, Atara Prices Public Offering

via: SeekingAlpha at 2018-01-05 01:36:56:000

Analysis of top Seeking Alpha coverage: ChemoCentryx Today we will discuss an update from ChemoCentryx ( CCXI ), which sent shares more than 30% higher in intra-day trading. ChemoCentryx is primarily focused on orphan and rare diseases. The companys lead product candidate is Avac… read more...

Your Daily Pharma Scoop: Ardelyx Reports Data, Omeros Moves Forward With OMS721, Allergan Announces Job Cuts

via: SeekingAlpha at 2018-01-04 02:17:49:000

Analysis of top Seeking Alpha coverage: Ardelyx Today we will discuss the announcement from Ardelyx ( ARDX ) with regards to the Phase 3 T3MPO program. The T3MPO program was designed to support the registration of tenapanor for the treatment of patients with irritable bowel syndrome with… read more...

Your Daily Pharma Scoop: Heron Enters 2018 On Strong Note, Teva Launches Generic Reyataz, Sarepta Top Smid-Cap Pick

via: SeekingAlpha at 2017-12-29 01:58:47:000

Analysis of top Seeking Alpha coverage: Heron Therapeutics Today we will be discussing one of the top performing stocks in the biotech sector this year, Heron Therapeutics ( HRTX ). After two disappointing years, HRTX is headed for gains of more than 40% for this year. Despite the rally, H… read more...

Premarket Gainers as of 9:05 am

via: SeekingAlpha at 2017-12-21 09:28:57:000

LTEA +351% on shifting its primary corporate focus towards the exploration of and investment in opportunities that leverage the benefits of blockchain technology. More news on: Long Island Iced Tea Corp., AEterna Zentaris, Inc., Net Element International, Inc., Stocks on the mo… read more...

Your Daily Pharma Scoop: Gilead's Potential, Celgene CAR-T Candidate, Cellectar Soars

via: SeekingAlpha at 2017-12-07 08:00:00:000

This abridged Daily Scoop is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. Total Pharma Tracker subscribers get the full version with actionable ideas one day ea… read more...

Your Daily Pharma Scoop: Dynavax Beyond Heplisav-B, Novartis' Cosentyx, Shire Granted ODD

via: SeekingAlpha at 2017-12-01 12:47:33:000

This abridged "Daily Scoop" is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. Analysis of top Seeking Alpha coverage: Dynavax Today we will focus on an article on Dynavax… read more...

Your Daily Pharma Scoop: Synergy In 2018, Repatha Action Date, Alkermes Signs Deal

via: SeekingAlpha at 2017-11-28 07:43:47:000

This abridged Daily Scoop is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. Analysis of top Seeking Alpha coverage: Synergy Pharma Today we will critique … read more...

Altimmune's (ALT) CEO Bill Enright on Q3 2017 Results - Earnings Call Transcript

via: SeekingAlpha at 2017-11-10 15:16:13:000

Altimmune, Inc. (ALT) Q3 2017 Earnings Conference Call November 10, 2017 08:30 ET Executives Ashley Robinson - Investor Relations Bill Enright - Chief Executive Officer Elizabeth Czerepak - Chief Financial Officer Analysts Charles Duncan - Piper Jaffray David Sherman - Li… read more...

Altimmune reports Q3 results

via: SeekingAlpha at 2017-11-09 16:25:29:000

Altimmune (NASDAQ: ALT ): Q3 EPS of -$2.05 Revenue of $4.59M (+410.0% Y/Y) Press Release More news on: Altimmune, Inc., Earnings news and commentary, Healthcare stocks news, , read more...

After Hours Gainers / Losers

via: SeekingAlpha at 2017-10-10 17:38:05:000

Top gainers, as of 5.25 p.m.: ALT +3.2% . CX +2.0% . MNKD +1.5% . ROKU +1.3% . SAVE +1.4% . More news on: Altimmune, Inc., Cemex, S.A.B. de C.V., MannKind Corporation, Stocks on the move, Read more … read more...

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
2017-02-06 2017-02-03 2017-01-24 2016-11-17 29.1 SP Dividend income
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
2017-05-05 10.0 1.0 10.0
Data provided for free by IEX